The global market for Digital High-speed Tablet Presses is projected to grow from USD 1,256 million in 2024 to USD 1,721 million by 2031, registering a compound annual growth rate (CAGR) of 4.6%, according to the latest Global Digital High-speed Tablet Presses Market Research Report 2025 by QYResearch.
Digital High-speed Tablet Presses
Key Manufacturers and Latest Innovations
Leading companies in the digital high-speed tablet press industry include Fette Compacting, KORSCH AG, IMA Group, GEA Group, Romaco Group, Bosch Packaging Technology, PTK Co., Ltd., Cadmach Machinery, Elizabeth Companies, Syntegon Technology, STC Engineering GmbH, Aurobindo Pharma, Natoli Engineering, Sejong Pharmatech, and Manesty.
In 2024, GEA introduced its cutting-edge NexGen Press series, designed to optimize efficiency with real-time data monitoring and predictive maintenance. Meanwhile, KORSCH AG unveiled the X 5 Tablet Press, tailored for high-output and fast changeovers in pharmaceutical production, reflecting the market’s demand for flexible, efficient machinery.
Application Areas
The Digital High-speed Tablet Presses are widely adopted across:
Pharmaceutical Industry
Nutraceutical Industry
Food Industry
Chemical Industry
Other industrial sectors
Product Types
Market segmentation by product type includes:
Single Punch Tablet Press
Rotary Tablet Press
Fully Automatic High-Speed Tablet Press
Multilayer Tablet Press
Others
Regional Market Outlook
Growth is expected across all major regions, with particular emphasis on North America, Europe, and Asia-Pacific. The Asia-Pacific market is predicted to see robust expansion due to increased pharmaceutical manufacturing investments in China, India, and Southeast Asia.
Key Trends in 2025
1. Industry 4.0 Integration
Industry 4.0 is playing a transformative role in digital high-speed tablet presses. These machines are increasingly equipped with IoT sensors, AI-based controls, and real-time monitoring systems. This trend is enhancing production efficiency, reducing machine downtime, and enabling data-driven decision-making across pharmaceutical manufacturing lines.
IoT Analytics reports that the number of connected IoT devices will grow to 18.8 billion by the end of 2024, a 13% increase year-on-year. This broad adoption across industries is propelling pharmaceutical companies to modernize their equipment with smart technologies for better traceability and automation.
2. Continuous Manufacturing Adoption
The shift from batch to continuous manufacturing (CM) is gaining traction in the pharmaceutical industry. Continuous tablet pressing enables consistent production with fewer interruptions, allowing manufacturers to better control quality and scale output more flexibly.
According to Pharmaceutical Technology (2024), CM offers reduced cycle times, real-time quality monitoring, and improved process efficiencies. CM is especially advantageous for personalized medicine and just-in-time production models that demand agility and precision.
3. Global Supply Chain Adaptations
The 2025 U.S. tariff policies have added complexity to global supply chains, prompting many pharmaceutical equipment manufacturers to diversify sourcing and production hubs. The recent tariff pause between the U.S. and China has not entirely alleviated uncertainty, encouraging firms to continue pursuing “China-plus-one” and nearshoring strategies.
Reuters (2025) notes that although the pause in tariffs provided short-term relief, companies are investing in facilities in Vietnam, Mexico, and India to reduce reliance on any single market and to build more resilient logistics frameworks.
4. Market Growth Momentum
Driven by rising demand for efficiency and precision, the global digital high-speed tablet presses market is expected to grow from USD 1,256 million in 2024 to USD 1,721 million by 2031, with a CAGR of 4.6% over the forecast period. Rotary and multilayer tablet presses remain the most sought-after types due to their high output capabilities and flexibility.
DataIntelo (2025) also highlights a strong growth trajectory for rotary tablet presses, projecting the segment to exceed USD 1.3 billion by 2032, supported by expanding pharmaceutical output in Asia-Pacific and government-backed healthcare investments.
5. Regulatory Pressures on Quality and Traceability
Stringent global regulations are reinforcing the need for highly accurate and traceable tablet production processes. To meet evolving GMP and FDA standards, manufacturers are adopting smart tablet presses that incorporate sensors and feedback loops to detect anomalies and ensure batch consistency.
According to recent updates shared on LinkedIn by industry experts, smart infrared tablet presses with AI-enabled diagnostics are being adopted not just for compliance, but also as a competitive differentiator in regulated markets.
As pharmaceutical and nutraceutical industries continue to demand high-volume, efficient, and data-integrated solutions, the Digital High-speed Tablet Presses market is set for steady growth. The combination of technological innovation, regional expansion, and evolving regulatory landscapes will shape the market’s trajectory through 2031.
Related Reports：
Global Digital High-speed Tablet Presses Market Research Report 2025
https://www.qyresearch.com/reports/4727494/digital-high-speed-tablet-presses
Digital High-speed Tablet Presses – Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
https://www.qyresearch.com/reports/4727493/digital-high-speed-tablet-presses
Global Digital High-speed Tablet Presses Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
https://www.qyresearch.com/reports/4727492/digital-high-speed-tablet-presses
Global Digital High-speed Tablet Presses Market Insights, Forecast to 2031
https://www.qyresearch.com/reports/4727491/digital-high-speed-tablet-presses
About Us
QYResearch founded in California, USA in 2007. It is a leading global market research and consulting company. With over 18 years’ experience and professional research team in various cities over the world QY Research focuses on management consulting, database and seminar services, IPO consulting, industry chain research and customized research to help our clients in providing non-linear revenue model and make them successful. We are globally recognized for our expansive portfolio of services, good corporate citizenship, and our strong commitment to sustainability. Up to now, we have cooperated with more than 66,000 clients across five continents. Let’s work closely with you and build a bold and better future.
Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
E-mail: global@qyresearch.com
Tel: 001-626-842-1666(US) 0086-133 1872 9947(CN)
EN: https://www.qyresearch.com
JP: https://www.qyresearch.co.jp